Bausch Health Companies Inc.

8.02+0.0100+0.12%Vol 2.13M1Y Perf 6.23%
Oct 4th, 2023 16:00 DELAYED
BID7.84 ASK8.08
Open8.03 Previous Close8.01
Pre-Market- After-Market8.02
 - -  - -%
Target Price
11.25 
Analyst Rating
Hold 2.83
Potential %
40.27 
Finscreener Ranking
     32.16
Insiders Trans % 3/6/12 mo.
-/-100/-37 
Value Ranking
     33.58
Insiders Value % 3/6/12 mo.
-/-100/46 
Growth Ranking
+     30.01
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/45 
Income Ranking
 —    -
Price Range Ratio 52W %
52.57 
Earnings Rating
Strong Buy
Market Cap2.92B 
Earnings Date
2nd Nov 2023
Alpha-0.01 Standard Deviation0.16
Beta0.97 

Today's Price Range

7.858.06

52W Range

5.5710.23

5 Year PE Ratio Range

-12.604.20

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-2.32%
1 Month
-5.32%
3 Months
2.43%
6 Months
6.09%
1 Year
6.23%
3 Years
-49.24%
5 Years
-69.77%
10 Years
-

TickerPriceChg.Chg.%
BHC8.020.01000.12
AAPL173.661.26000.73
GOOG136.272.97002.23
MSFT318.965.56501.78
XOM111.50-4.3300-3.74
WFC38.970.30000.78
JNJ155.520.18000.12
FB196.640.99000.51
GE108.851.09001.01
JPM143.350.64000.45
Financial StrengthValueIndustryS&P 500US Markets
0.60
1.00
0.98
44.72
1.20
Leverage Ratio -57.50
ProfitabilityValueIndustryS&P 500US Markets
70.90
21.50
38.70
-20.30
3.34
RevenueValueIndustryS&P 500US Markets
6.12B
16.93
-2.78
-2.71
Earnings HistoryEstimateReportedSurprise %
Q02 20230.750.818.00
Q01 20230.750.52-30.67
Q04 20220.921.0210.87
Q03 20220.920.76-17.39
Q02 20220.890.55-38.20
Q01 20221.030.72-30.10
Q04 20211.081.2717.59
Q03 20211.071.146.54
Earnings Per EndEstimateRevision %Trend
9/2023 QR0.922.22Positive
12/2023 QR1.03-2.83Negative
12/2023 FY3.290.92Positive
12/2024 FY3.60-1.64Negative
Next Report Date2nd Nov 2023
Estimated EPS Next Report0.92
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume2.13M
Shares Outstanding364.33K
Shares Float275.99M
Trades Count14.52K
Dollar Volume16.93M
Avg. Volume2.63M
Avg. Weekly Volume1.86M
Avg. Monthly Volume3.23M
Avg. Quarterly Volume2.82M

Bausch Health Companies Inc. (NYSE: BHC) stock closed at 8.01 per share at the end of the most recent trading day (a -1.6% change compared to the prior day closing price) with a volume of 2.65M shares and market capitalization of 2.92B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 21600 people. Bausch Health Companies Inc. CEO is Joseph C. Papa.

The one-year performance of Bausch Health Companies Inc. stock is 6.23%, while year-to-date (YTD) performance is 27.55%. BHC stock has a five-year performance of -69.77%. Its 52-week range is between 5.5703 and 10.23, which gives BHC stock a 52-week price range ratio of 52.57%

Bausch Health Companies Inc. currently has a PE ratio of 9.70, a price-to-book (PB) ratio of 18.74, a price-to-sale (PS) ratio of 0.45, a price to cashflow ratio of 3.90, a PEG ratio of 0.49, a ROA of 0.99%, a ROC of 1.49% and a ROE of -72.80%. The company’s profit margin is 3.34%, its EBITDA margin is 38.70%, and its revenue ttm is $6.12 Billion , which makes it $16.93 revenue per share.

Of the last four earnings reports from Bausch Health Companies Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.92 for the next earnings report. Bausch Health Companies Inc.’s next earnings report date is 02nd Nov 2023.

The consensus rating of Wall Street analysts for Bausch Health Companies Inc. is Hold (2.83), with a target price of $11.25, which is +40.27% compared to the current price. The earnings rating for Bausch Health Companies Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bausch Health Companies Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bausch Health Companies Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 27.56, ATR14 : 0.29, CCI20 : -118.87, Chaikin Money Flow : -0.05, MACD : -0.10, Money Flow Index : 32.62, ROC : -5.99, RSI : 40.38, STOCH (14,3) : 36.59, STOCH RSI : 0.00, UO : 43.51, Williams %R : -63.41), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bausch Health Companies Inc. in the last 12-months were: Seana Carson (Sold 8 252 shares of value $69 898 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (16.67 %)
0 (0.00 %)
1 (16.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
4 (66.67 %)
5 (83.33 %)
4 (66.67 %)
Moderate Sell
1 (16.67 %)
1 (16.67 %)
1 (16.67 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
2.83
Hold
3.17
Hold
2.83

Bausch Health Companies Inc.

Bausch Health Companies Inc is a multinational, specialty pharmaceutical and medical device company that develops, manufactures and markets a broad range of branded generic pharmaceuticals, over-the-counter products and medical devices. The company operating business segments are Bausch+Lomb and international, Salix pharmaceuticals, ortho dermatology, and diversified products.

CEO: Joseph C. Papa

Telephone: +1 514 744-6792

Address: 2150 Saint Elzear Boulvard West, Laval H7L 4A8, QC, CA

Number of employees: 21 600

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

48%52%

Bearish Bullish

55%45%

Bearish Bullish

55%45%

 

TipRanks News for BHC

Wed, 20 Sep 2023 09:07 GMT Bausch Health upgraded to Buy from Hold at Jefferies

- TipRanks. All rights reserved.

News

Stocktwits